The Digest: April 2025
In this month's news, a flurry of 510(k) clearances (and one De Novo) and major M&A plays by Viscogliosi Brothers, Zydus Lifesciences, and more.
MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today
Browse Latest IssueIn this month's news, a flurry of 510(k) clearances (and one De Novo) and major M&A plays by Viscogliosi Brothers, Zydus Lifesciences, and more.
We present selected private financings for February and March and this month's VC snapshot features early-stage medtech investor Nina Capital.
We present selected private financings for February and March and this month's VC snapshot features early-stage medtech investor Nina Capital.